STAAR Surgical Company
STAAHealthcareNASDAQMedical Instruments & Supplies · Last scanned May 30, 2026
Scan Results
Daily timeframeHeadquartered within the healthcare sector, STAAR Surgical Company focuses on Medical Instruments & Supplies services and products. STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, and sells phakic implantable lenses for the eye and accessory delivery systems to deliver the lenses into the. The $1.49B market capitalization puts STAA squarely in small-cap range for its industry. The company offers implantable collamer lens product family (ICLs) comprising EVO ICL, EVO+ ICL, EVO Visian ICL, and EVO Viva ICL for use in refractive surgery for the treatment of visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia.
Market Cap
$1.49B
Beta
1.20
P/E (TTM)
—
P/E (Fwd)
30.27
EPS (TTM)
$-0.42
EPS (Fwd)
$0.99
ROE
-6.0%
ROA
0.9%
Cash
$163.9M
Total Debt
$37.3M
Free CF
-$17.5M
52W Change
79.1%
Annual Financials
Cash vs Debt
With $163.9M in cash and $37.3M in debt, STAA maintains more liquidity than leverage. This favorable balance sheet position can be an asset when capital markets become less accommodating. The company is burning cash, with free cash flow at -$17.5M. This typically occurs when a company is investing aggressively in growth, but sustained cash burn can strain the balance sheet. ROE of -6.0% points to negative capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. ROA of 0.9% is on the lower side, which is common in asset-heavy industries. Revenue has pulled back from $284.4M (2022) to $239.4M (2025), a 16% decline worth watching.
The strong cash position relative to debt provides a financial cushion that reduces balance sheet risk. Negative free cash flow means the company is currently spending more than it generates, which may require future fundraising or debt if the trend continues. No single metric tells the full story. Reviewing STAA's risk profile alongside its fundamentals and technical indicators provides a more complete picture.